6.72
+0.19
+(2.91%)
At close: January 30 at 4:00:01 PM EST
6.13
-0.59
(-8.78%)
Pre-Market: 4:35:03 AM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
89,612.00
108,168.00
Total Liabilities Net Minority Interest
428,872.00
303,410.00
Total Equity Gross Minority Interest
-339,260.00
-195,242.00
Total Capitalization
-339,260.00
-195,242.00
Common Stock Equity
-339,260.00
-195,242.00
Capital Lease Obligations
32,580.00
1,779.00
Net Tangible Assets
-339,260.00
-195,242.00
Working Capital
32,486.00
89,203.00
Invested Capital
-339,260.00
-195,242.00
Tangible Book Value
-339,260.00
-195,242.00
Total Debt
32,580.00
1,779.00
Share Issued
51,844.73
51,844.73
Ordinary Shares Number
51,844.73
51,844.73
12/31/2022 - 6/28/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LXEO Lexeo Therapeutics, Inc.
5.25
+0.77%
MBX MBX Biosciences, Inc.
11.64
+13.34%
AVBP ArriVent BioPharma, Inc.
29.09
+0.24%
ARTV Artiva Biotherapeutics, Inc.
5.40
+0.37%
BCAX Bicara Therapeutics Inc.
12.91
+9.78%
ZBIO Zenas BioPharma, Inc.
7.62
+4.53%
SEPN Septerna, Inc.
17.71
+13.89%
UPB Upstream Bio, Inc.
11.00
+7.32%
CGON CG Oncology, Inc.
30.15
-0.46%
PLRX Pliant Therapeutics, Inc.
10.66
-0.74%